2-difluoromethylornithine (DFMO), a suicide inhibitor of ODC, suppresses cancer cell survival in mouse models and is being tested for its efficacy in cancer chemoprevention and the treatment of malignancies such as neuroblastoma3,4. This evidence concerns the gene ODC1 and cancer.